While on testosterone replacement, hemoglobin and hematocrit levels should be monitored. Levels suggestive of excessive erythrocytosis or abuse are:
A) Hemoglobin 14 g/dL or hematocrit 39%
B) Hemoglobin 11.5 g/dL or hematocrit 31%
C) Hemoglobin 13 g/dL or hematocrit 38%
D) Hemoglobin 17.5 g/dL or hematocrit 54%
Correct Answer:
Verified
Q1: When assessing a male for hypogonadism prior
Q3: When prescribing phosphodiesterase type 5 (PDE-5) inhibitors
Q4: Some research supports that testosterone replacement therapy
Q5: Male patients who should not be prescribed
Q6: The factor that has the greatest effect
Q7: Monitoring of male patients who are using
Q8: Men who are prescribed PDE-5 inhibitors for
Q9: The goal of testosterone replacement therapy is:
A)Absence
Q10: Monitoring of an older male patient on
Unlock this Answer For Free Now!
View this answer and more for free by performing one of the following actions
Scan the QR code to install the App and get 2 free unlocks
Unlock quizzes for free by uploading documents